NCT06497673View on ClinicalTrials.gov

Sanger Human Cell Atlasing Project

Enrolling by invitationOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

December 16, 2019

Primary Completion Date

November 7, 2029

Study Completion Date

November 7, 2029

Conditions
Human DevelopmentGenetic Disease
Interventions
OTHER

sample collection

New collected samples, as well as surplus surgical and diagnostic samples.

Trial Locations (1)

Unknown

Wellcome Sanger Institute, Cambridge

All Listed Sponsors
lead

The Wellcome Sanger Institute

OTHER